GZMH and type 2 diabetes mellitus: CGL2 patients with biallelic null mutations in BSCL2 suffer from early premature aging signs, including regional atrophy of subcutaneous tissues, as well as cardiovascular lesions, type 2 diabetes and psychomotor abnormalities.